Scaling up PSC-derived cell therapies from 2D to 3D
08 Sept 2026
Cell Therapy Development
- What are the primary challenges and opportunities associated with PSC expansion?
- How does differentiation perform within a biologic-like bioreactor?
- How can we maintain genomic integrity during the transition from small-scale (0.5L) to large-scale (80–300L) bioreactor systems?
